期刊文献+

手术治疗的良性前列腺增生患者PSA水平增高的相关因素分析 被引量:3

The analysis of correlated factors about the serum prostate specific antigen in the benign prostatic hyperplasia patients who had received operation
下载PDF
导出
摘要 目的:了解手术治疗的良性前列腺增生患者PSA水平增高的相关因素。材料和方法:选取手术治疗的良性前列腺增生患者共369例,取患者的PSA、前列腺体积、残余尿、最大尿流率及国际前列腺症状评分(IPSS)共5项指标进行相关性分析。结果:手术治疗的良性前列腺增生患者血清PSA水平与前列腺体积和年龄呈显著正相关。患者的IPSS与血清PSA水平具有一定的正相关性。患者的PSA与残余尿量和最大尿流率均无明显相关性。结论:在影响血清PSA的相关因素中,年龄、前列腺体积对血清PSA的水平起决定性作用;IPSS可能在一定程度上和PSA的水平相关。 Objective: To study the correlated factors about the serum prostate specific antigen in the benign prostatic hyperplasia patients who had received operation. Menthods: A total of 369 inpatients with benign prostatic hyperplasia who had received operation were analyzes retrospectively. Their PSA, prostate volume, residual urine, maximum urine rate of flow and international prostate symptom score (IPSS) were analyzed. Results: In the benign prostatic hyperplasia patients, the serum PSA is positively correlated with the age and prostate volume. IPSS is possiblely correlated with PSA, while there is no obvious correlation between serum PSA and residual urine or maximum urine rate of flow. Conclusions : Among these related factors affecting serum PSA, the age and prostate volume play a decisive role. Exact IPSS score is positively correlated with PSA in certain degree. However, there is no obvious correlation between serum PSA and residual urine or maximum urine rate of flow.
出处 《陕西医学杂志》 CAS 北大核心 2005年第11期1324-1326,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献9

  • 1Oesterling JE, Jacobsen SJ, Chute CG,et al. Serum prostate prostate specific antigen in a community-based population of healthmen establishment of age specific references ranges.JAMA,1993;270:860
  • 2Haese A, Graefen M, Steuber T, et al. Total and Gleason grade 415 cancer volumes are major contributors of human hallihrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign rostatic biopsies. J Urol,2003;170(6. Pt 1):2269
  • 3Leslie A, Kalish, John B, et al. Serum prostate specific antigen levels (PSA) in men without clinical evidence of prostate cancer:Age-specific reference ranges for total PSA, free PSA and percent free PSA. Urology, 1999;54(6):1024
  • 4Oesterling JE, Kumamoto Y, Tsukamoto T, et al. Serum , prostate-specific antigen in a Community-based population of health Japanese men: Lower values than for similarly aged white men. Br J Urol,1995;75:347
  • 5Collins GN ,Lee RJ ,Mckelivie GB .Relationship between Prostate-specific antigen prostate Volume and age in the benign prostate.Br J Urol,1993;71:445
  • 6Wu B ,Itoh Y,Saitoh M,The realationship betweenserum PSA value and the weight of the inner gland of the prostate in in the cases of benign prostatc hypoplasix.Nippon Hinyokika Gakai Easshi,1995;86:1525
  • 7Zackrisson B, Aus G, Lilka H. et al. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur Uro1. 2003; 43(4):327
  • 8Bosch JR ,Hop WC,Bangma CH, et al. Prostate specific antigen in a conmiunitybased sample of men without prostate cancer: correlations with prostate wolume ,age ,body imss index ,and symptoms of protatisim. Prostate,1995;27:241
  • 9Marc E,Laniad O,Jeremy l,et al.Serum prostate-specific antigen to presence of bladder utlet obstruction in men with urinary sympoms. Bju Intertional,2004;94:1283

同被引文献22

  • 1黄伟刚,赖建生,林津,许胜利.健康男性与前列腺疾病患者的血清前列腺特异抗原水平差异[J].新医学,2004,35(9):551-552. 被引量:3
  • 2Oesterling JE, Kumamoto Y, Tsukamoto T, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol, 1995, 75(1): 347-353.
  • 3Lepor H, Wang B, Shapiro E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. J Urology , 2006,44 (4) : 199-205.
  • 4Martha K, Naveed A, John N, et al . Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate and post-void residual urine volume. J Urol, 1998,52(3) : 462-466.
  • 5Catalona WJ, Partin AW, Slawin KM, et al . Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: aprospective multicenter clinical trial. JAMA, 1998,279(13) :1542-1547.
  • 6Pollack A, Smith LG, Von-Eschenbach AC. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys , 2005,48(7) : 507-512.
  • 7Mardy D ,Ger E ,Tom A versus age, prostate Symptoms volume, parameters in 565 strictly selected and quality of life and urodynamic men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. J Urol ,2001,57(4):695-700.
  • 8Viario BO , Manuel V, Renata M, et al . Relationship between prostatic specific antigen (PSA) and volume of the prostate in the benign prostatic hyperplasia in the elderly. J Oneology Hematology ,2003,47(6) :207-211.
  • 9Babain 1LI, Miyashita H, Evans RB, etal. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age.J Urol 1992; 147(3 Pt 2): 837- 840.
  • 10Oesterling JE, Jacobsen S J, Chute CG, et al. Serum prostate specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993; 270(7): 860-864.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部